Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
33.67
-0.25 (-0.74%)
Oct 14, 2025, 3:33 PM EDT - Market open
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $2.25 billion as of October 14, 2025. Its market cap has increased by 16.21% in one year.
Market Cap
2.25B
Enterprise Value
-1.31B
1-Year Change
16.21%
Ranking
Category
Stock Price
$33.67
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $2.25B, an increase of 20.96%. That is a compound annual growth rate of 1.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 2.24B | 23.34% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
| May 14, 2015 | 1.86B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 748.25B |
| Johnson & Johnson | 459.32B |
| AbbVie | 407.19B |
| UnitedHealth Group | 321.06B |
| AstraZeneca | 264.75B |
| Novo Nordisk | 260.80B |
| Novartis AG | 253.85B |
| Abbott Laboratories | 230.73B |